REVVITY, INC.

RVTY · NYSE · SIC 3826: Laboratory Analytical Instruments · Market Cap: $9.9B · 11,000 employees
214
SEC Filings
$100.52
Close 2026-06-01
3
Transcripts
11,000
Employees

Business Summary

Overview We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing whats possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Our headquarters are in Waltham, Massachusetts, and we market our products and ...

Latest Stock Quote

RVTY 2026-06-01 $100.52 O:$103.92 H:$104.645 L:$100.17 Vol:2.2M VWAP:$101.3823
origin leaf: 61f38d8e3657795d176a662440af2bf92fb7345c2e31e1954b906e587ef2f3de

Next Earnings

expected 2026-07-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRVTYdiscussed Healthcare & Bio
topic_mentionRVTYdiscussed Artificial Intelligence
topic_mentionRVTYdiscussed Cloud Computing
topic_mentionRVTYdiscussed Regulation
topic_mentionRVTYdiscussed Healthcare & Bio
topic_mentionRVTYdiscussed Artificial Intelligence
topic_mentionRVTYdiscussed Regulation
topic_mentionRVTYdiscussed Healthcare & Bio
topic_mentionRVTYdiscussed Platform & Ecosystem
metricRVTY gross marginreported $28.0 percent
topic_mentionRVTYdiscussed Artificial IntelligenceQ4 FY2025
topic_mentionRVTYdiscussed Cloud ComputingQ4 FY2025
topic_mentionRVTYdiscussed CybersecurityQ4 FY2025
topic_mentionRVTYdiscussed Blockchain & CryptoQ4 FY2025
topic_mentionRVTYdiscussed Capital ExpenditureQ4 FY2025
topic_mentionRVTYdiscussed Supply ChainQ4 FY2025
topic_mentionRVTYdiscussed RegulationQ4 FY2025
topic_mentionRVTYdiscussed Sovereign & GovernmentQ4 FY2025
topic_mentionRVTYdiscussed AutomotiveQ4 FY2025
topic_mentionRVTYdiscussed Healthcare & BioQ4 FY2025

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-280000031791-26-000012EDGAR53K words
2025-02-252024-12-290000031791-25-000009EDGAR
2024-02-272023-12-310000031791-24-000004EDGAR
2023-03-012023-01-010000031791-23-000004EDGAR
2022-03-032022-01-020000031791-22-000003EDGAR
2021-03-022021-01-030000031791-21-000003EDGAR
2020-02-252019-12-290000031791-20-000003EDGAR
2019-02-262018-12-300000031791-19-000003EDGAR
2018-02-272017-12-310000031791-18-000004EDGAR
2017-02-282017-01-010000031791-17-000003EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-280000031791-25-000037EDGAR24K words
2025-08-052025-06-290000031791-25-000026EDGAR
2025-05-062025-03-300000031791-25-000015EDGAR
2024-11-062024-09-290000031791-24-000028EDGAR
2024-08-062024-06-300000031791-24-000021EDGAR
2024-05-072024-03-310000031791-24-000014EDGAR
2023-11-072023-10-010000031791-23-000014EDGAR
2023-08-092023-07-020000031791-23-000011EDGAR
2023-05-122023-04-020000031791-23-000008EDGAR
2022-11-142022-10-020000031791-22-000012EDGAR
2022-08-092022-07-030000031791-22-000009EDGAR
2022-05-102022-04-030000031791-22-000006EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-020000031791-26-000007EDGAR9K words
2026-01-130000031791-26-000003EDGAR
2025-10-270000031791-25-000032EDGAR
2025-10-240001193125-25-249958EDGAR
2025-07-280000031791-25-000022EDGAR
2025-04-280000031791-25-000012EDGAR
2025-04-250001193125-25-096747EDGAR
2025-01-310000031791-25-000006EDGAR
2025-01-130000031791-25-000003EDGAR
2025-01-070001193125-25-002871EDGAR

214 total filings indexed. 182 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
RVTY Earnings Call Transcript
RVTY Earnings Call Transcript
Q4 FY2025RVTY Q4 FY2025 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

TXG — 10x Genomics, Inc. A — AGILENT TECHNOLOGIES, INC. ASTC — ASTROTECH Corp AVTR — Avantor, Inc. BIO — BIO-RAD LABORATORIES, INC. BFNH — BIOFORCE NANOSCIENCES HOLDINGS, INC. BRKR — BRUKER CORP BNGO — Bionano Genomics, Inc.

Company Identity

CIK0000031791
TickerRVTY
ExchangeNYSE
SIC3826: Laboratory Analytical Instruments
IncorporatedMA
Websitehttps://www.revvity.com
Listed1972-06-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 06d906f32608a896f69f0001d81e52abb9d383a2557cb6afaa9094d8fd646570
parent: c8b66ed0c7c86ac60d884fc06b62ca353886db6c6fa37a275ae69269b9259de4
content hash: 7fa8c25fa3d825457756d0edbb74dd1339253b1754c6f8859f3637a78bcac705
signed: 2026-06-02T19:02:31.570Z
sources: 26 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf